Ask AI
Bill115th CongressFiled May 15, 2018Health
H.R. 5808

Medicaid Pharmaceutical Home Act of 2018

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary reported to house without amendment (Jun 12, 2018)

Medicaid Pharmaceutical Home Act of 2018

This bill requires state Medicaid programs to establish drug-management programs for at-risk beneficiaries (those identified as at risk of abusing or misusing controlled substances).

What just happenedJun 12, 2018

Placed on the Union Calendar, Calendar No. 561.

Who’s behind it

Rep. Bilirakis, Gus M. [R-FL-12](R-FL)Sponsor
3 cosponsors1 D2 R
Read on Congress.gov
3cosponsors1committees8actions1related bills12subjects
  1. Jun 12, 2018CalendarsH12410

    Placed on the Union Calendar, Calendar No. 561.

  2. Jun 12, 2018CommitteeH12200

    Reported by the Committee on Energy and Commerce. H. Rept. 115-726.

    Energy and Commerce Committee
  3. Jun 12, 2018Committee5000

    Reported by the Committee on Energy and Commerce. H. Rept. 115-726.

    Energy and Commerce Committee
  4. May 17, 2018Committee

    Ordered to be Reported by Voice Vote.

    Energy and Commerce Committee
  5. May 17, 2018Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  6. May 15, 2018IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  7. May 15, 2018IntroReferralIntro-H

    Introduced in House

  8. May 15, 2018IntroReferral1000

    Introduced in House

Reported to House without amendmentJun 12, 201879

Medicaid Pharmaceutical Home Act of 2018

This bill requires state Medicaid programs to establish drug-management programs for at-risk beneficiaries (those identified as at risk of abusing or misusing controlled substances).

Introduced in HouseMay 15, 2018

Medicaid Pharmaceutical Home Act of 2018

This bill requires state Medicaid programs to establish drug-management programs for at-risk beneficiaries (those identified as at risk of abusing or misusing controlled substances).

Medicaid Pharmaceutical Home Act of 2018 — Informed